Targeted Disease(s):
Lung Cancer
Purpose of Study:
International registry for cancer patients evaluating the feasibility and clinical utility of an Artificial Intelligence-based precision oncology clinical trial matching tool, powered by a virtual tumor boards (VTB) program, and its clinical impact on pts with advanced cancer to facilitate clinical trial enrollment (CTE), as well as the financial impact, and potential outcomes of the intervention.
Study Dates:
January 1, 2018 - December 1, 2022
Study Design:
Observational Design
Study Location:
Nationwide
Lead Institution:
Massive Bio, Inc.
ClinicalTrails.gov Identifier:
NCT03452774
